This article addresses some of the controversies about the role of benzodiazepines in the treatment of posttraumatic stress disorder.
Conclusions:
Benzodiazepines have been admonished in treatment guidelines for posttraumatic stress disorder, but this is based on very little solid evidence. Although benzodiazepines do not seem to be effective in the treatment of the core posttraumatic stress disorder symptoms, their careful use as adjunctive agents for the symptoms such as anxiety and sleep disturbance may be useful. Future research needs to identify predictors of improved treatment outcomes in posttraumatic stress disorder with use of benzodiazepines.
LundBCBernardyNCAlexanderB. Declining benzodiazepine use in veterans with posttraumatic stress disorder. J Clin Psychiatry2012; 73: 292–296.
2.
KatzmanMABleauPBlierP. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry2014; 14(Suppl. 1): 1-83.
3.
BaldwinDSAndersonIMNuttDJ. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol2014; 28: 403–439.
4.
Veterans Health Administration, Department of Defense. VA/DoD clinical practice guideline for management of post-traumatic stress. Version 2.0–2010, www.healthquality.va.gov/PTSD-Full-2010c.pdf (2010, accessed 26 October 2016).
5.
FoaEBKeaneTMFriedmanMJ. (eds) Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies, 2nd ed.New York: Guilford Press, 2009.
6.
BandelowBZoharJHollanderE. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry2008; 9: 248–312.
7.
HoodSD. Latest guidelines for the management of the anxiety disorders – A report from the International Anxiety Disorders Society Conference, Melbourne 2014. Australas Psychiatry2015; 23: 388–391.
8.
RothLS. PTSD and benzodiazepines: A myth agreed upon. Fed Pract2010; 27: 12–21.
9.
BraunPGreenbergDDasbergH. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry1990; 51: 236–238.
10.
RothbaumBOPriceMJovanovicT. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. Am J Psychiatry2014; 171: 640–648.
11.
NeylanTC. Pharmacologic augmentation of extinction learning during exposure therapy for PTSD. Am J Psychiatry2014; 171: 597–599.
12.
MellmanTABustamanteVDavidD. Hypnotic medication in the aftermath of trauma. J Clin Psychiatry2002; 63: 1183–1184.
13.
CatesMEBishopMHDavisLL. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. Ann Pharmacother2004; 38: 1395–1399.
14.
GuinaJRossetterSRDeRhodesBJ. Benzodiazepines for PTSD: A systematic review and meta-analysis. J Psychiatr Pract2015; 21: 281–303.
15.
NordmannAJKasendaBBrielM. Meta analyses: What they can and cannot do. Swiss Med Wkly2012; 142: w13518.
16.
KostenTRFontanaASernyakMJ. Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse. J Nerv Ment Dis2000; 188: 454–459.
17.
ShinHJRosenCSGreenbaumMA. Longitudinal correlates of aggressive behavior in help-seeking U.S. veterans with PTSD. J Trauma Stress2012; 25: 649–656.
18.
RisseSCWhittersABurkeJ. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. J Clin Psychiatry1990; 51: 206–209.
19.
RosenCSGreenbaumMASchnurrPP. Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?J Clin Psychiatry2013; 74: 1241–1248.
